ReviewDrug design, development and therapy2016

Potential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemia.

Caroline Le Jeune et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.